| dc.date.accessioned | 2023-11-07T17:38:44Z | |
| dc.date.available | 2023-11-07T17:38:44Z | |
| dc.date.issued | 2022-07-26 | |
| dc.identifier | pat11395850 | |
| dc.identifier.uri | https://hdl.handle.net/11244/339970 | |
| dc.description.abstract | Recombinant, live, attenuated viruses of the Pneumoviridae family are disclosed that include a baculovirus GP64 envelope glycoprotein or variant or fragment thereof and a respiratory syncytial virus (RSV) F protein variant or fragment thereof. Also disclosed are polynucleotides encoding the virus as well as pharmaceutical compositions and vaccines containing the virus. In addition, methods of producing and using each of the above compositions are also disclosed. | |
| dc.format | application/pdf | |
| dc.format.extent | 43 pages | |
| dc.language | en_US | |
| dc.publisher | U.S. Patent and Trademark Office | |
| dc.title | RSV vaccines and methods of production and use thereof | |
| dc.type | Text | |
| osu.filename | pat11395850.pdf | |
| osu.accesstype | Open Access | |
| dc.type.genre | Patent | |
| dc.contributor.inventor | Oomens, Antonius G. P. | |
| dc.identifier.patentID | 11395850 | |
| dc.date.filed | 2020-09-09 | |
| dc.contributor.assignee | The Board of Regents for Oklahoma State University | |
| dc.subject.cpcclasses | A61K 39/12 (2013.01) | |
| dc.subject.cpcclasses | A61K 39/39 (2013.01) | |
| dc.subject.cpcclasses | A61P 31/12 (2018.01) | |
| dc.subject.cpcclasses | A61P 31/14 (2018.01) | |
| dc.subject.cpcclasses | C12N 7/00 (2013.01) | |
| dc.subject.cpcclasses | A61K 2039/5254 (2013.01) | |
| dc.subject.cpcclasses | A61K 2039/575 (2013.01) | |
| dc.subject.cpcclasses | C12N 2710/14052 (2013.01) | |
| dc.subject.cpcclasses | C12N 2760/18534 (2013.01) | |
| dc.subject.cpcclasses | C12N 2760/18562 (2013.01) | |
| dc.subject.cpcclasses | C12N 2760/18571 (2013.01) | |
| dc.subject.cpcclasses | C12N 2710/14122 (2013.01) | |
| dc.subject.cpcclasses | C12N 2810/6006 (2013.01) | |
